Commissione Scientifica Internazionale
Selezione dei progetti
I revisori selezionano i progetti valutandone gli aspetti di qualità, originalità, innovazione e fattibilità.
Dal 2009 hanno collaborato con la Fondazione nel processo di valutazione delle proposte di ricerca 128 ricercatori di base e/o clinici, provenienti da Europa, Stati Uniti d’America, Canada e altri paesi.
Ai membri dell’ISC viene richiesto di garantire l’assenza di conflitti di interesse per ogni proposta progettuale ricevuta e di mantenere la confidenzialità in merito a tutte le informazioni con le quali vengono in contatto.
Per minimizzare il rischio di conflitti di interesse, tutti questi esperti non lavorano in Italia.
Distribuzione geografica dei membri della Commissione Scientifica Internazionale di AriSLA (2009-2022)
Elenco dei membri dell’ISC 2022 di Fondazione AriSLA
- Andjus Pavle R, University of Belgrade, Serbia
- Bowser Robert, Barrow Neurological Institute Phoenix, AZ, USA
- Clement Albrecht M, Joannes Gutemberg, University of Mainz, Germany
- Da Cruz Sandrine, VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium
- Donnelly Christopher J., University of Pittsburgh School of Medicine, PA, USA
- Dupuis Luc, INSERM, Université de Strasbourg, Fédération de Médecine Translationnelle (FMTS), France
- Elliot David, Newcastle University Biosciences Institute, The International Centre for Life, New Castle, UK
- Fraenkel Ernest, Massachusetts Institute of Technology, Cambridge, MA, USA
- Fratta Pietro, University College London Hospitals (NHS Foundation Trust), London, UK
- Glass Jonathan, Emory University Department of Neurology & Pathology, Atlanta, Georgia, USA
- Greensmith Linda, The Graham Watts Laboratories for Research into Motor Neuron Disorders, UCL, London, UK
- Hedlund Eva, Department of Biochemistry and Biophysics, Stockholm University, Sweden Kabashi Edor, ICM – Hôpital Pitié Salpêtrière, Paris, France
- Kalb Robert G, Children’s Hospital of Philadelphia, Abramson Research Center, Philadelphia, PA, USA
- Kirby Janine, Department of Neuroscience, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK
- Link Christopher, Department of Integrative Physiology, University of Colorado Boulder, CO, USA
- Maragakis Nicholas, The Johns Hopkins Hospital Department of Neurology, Baltimore, MD, USA
- Marchand-Pauvert Veronique, Laboratoire d’Imagerie Biomédicale (LIB), Pitié-Salpêtrière Hospital (Paris, France) INSERM
- Moreira João Nuno, CNC – Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal
- Ozdinler Pembe Hande, Northwestern University, Chicago, IL, USA
- Petrucelli Leonard, Mayo Clinic Jacksonville, FL, USA
- Re Diane Berengere, Department of Pathology and Cell Biology, Center for Motor Neuron Disease, Department of Neurology, Columbia
- University, New York, NY, USA Rogelj Boris, Jožef Stefan Institute, and at Faculty of Chemistry and Chemical Technology, University of Ljubljana, Slovenia
- Sendtner Michael, Institute of Clinical Neurobiology, University of Wuerzburg, Germany
- Sibley Christopher R., University of Edinburgh, Edinburgh, Scotland, UK
- Suzuki Masatoshi, University of Wisconsin-Madison, Madison, WI, USA
- Van Den Bosch Ludo, VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium
- Vande Velde Christine, CHUM Research Centre, Université de Montréal, Montreal, Quebec, Canada